Anti-aging medicine is a $5 billion industry. Despite its critics, researchers are discovering that interventions designed to turn back time may prove to be more science than fiction.
Exploring the growing need of and up-to-date research for a universal flu vaccine.
For resuscitation of patients with sepsis, the verdict is in: Hydroxyethyl starch products increase the risk of acute kidney injury and death.
With the advent of new products with new manufacturing processes and added protection, the number of available influenza vaccine presentations has risen to 13. Which ones to choose for your patients can be simplified with a look at the pros and cons of the new compared with the traditional.
New breakthroughs are giving developing countries the best shot at disease-free living and longevity, but challenges of financing, delivery strategies, efficacy and safety remain.
With the increasing number of avian influenza outbreaks, many fear a possible bird flu pandemic. But, fears could be diminished by a better understanding of these flu strains.
Following today’s recommended childhood immunization schedule results in improved protection against at least 14 different diseases during the first years of life. As the series continues to evolve, parents and scientists alike are working to ensure the childhood series is safe, while looking for ways to make compliance even easier.
Counterfeits pose a threat for healthcare professionals worldwide. And, while technological advancements are being made to protect the drug supply, international regulation and politics stand in the way of fixing the problem in the foreseeable future.
Chronic fatigue syndrome is a legitimate medical condition that needs to be better understood by the medical community to help patients manage their disease and scientists to develop effective treatments.
Researchers are studying the effects of chronic inflammation on some of the world’s deadliest diseases and how it can be managed and prevented
The federal government, physicians and consumers all have active roles to play in reducing medication errors that so often result in adverse drug events and a high cost burden.
As the provisions of the PPACA are being put into effect, many questions and concerns remain among all sectors.